相关实验视频
Updated: Jun 25, 2025

Detecting Anastasis In Vivo by CaspaseTracker Biosensor
Published on: February 1, 2018
在癌症幸存者中发生第二次主要甲状腺癌的风险
Yewei Yuan1, Peng Sun2, Hualin Xiao2
1Department of Breast Surgery, Sichuan Provincial Maternity and Child Health Care Hospital, No. 290 West Second Street, Shayan Road, Chengdu, 610031, Sichuan, China.
癌症病史和癌症治疗增加了患第二种原发性甲状腺癌 (SPTC) 的风险. 特定的前癌症和早期治疗显著提高了SPTC风险,尽管在匹配后的生存率与原发性甲状腺癌相似.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 以前的癌症史和癌症治疗可能会增加患甲状腺癌 (TC) 的风险.
- 第二次原发性甲状腺癌 (SPTC) 的确切风险和特征需要进一步调查.
研究的目的:
- 评估SPTC的标准化发病率 (SIR) 与各种先前条件相关.
- 与初级TC相比,分析SPTC患者的临床病理特征和生存结果.
主要方法:
- 利用美国监测,流行病学和最终结果 (SEER) 计划 (1975-2019) 的数据.
- 计算SIRs,分析临床病理特征,并使用Kaplan-Meier方法评估生存率.
- 员工倾向性得分匹配 (PSM) 以平衡SPTC和初级TC组之间的共变量.
主要成果:
- 在患有先前瘤的患者中,TC的SIR显著高于一般人群 (0.94/10,000) (1.51/10,000).
- 急性淋巴细胞白血病,霍奇金淋巴瘤,唾液腺癌和癌与最高的SPTC风险有关.
- 35岁之前的放射治疗/化疗显著增加了TC发病率. SPTC患者的诊断是在年龄较大时进行的,并且有更高等级的瘤.
- 最初,SPTC显示出更糟糕的预后,但PSM使得SPTC和初级TC组之间的生存结果相当.
结论:
- 患有癌症史的患者患上SPTC的风险较高.
- 特定的先前恶性瘤和早期癌症治疗是SPTC的重要风险因素.
- 尽管初始呈现有差异,但SPTC的长期存活率在考虑混因素后与初级TC相当.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
相关概念视频
Cancer Prevention
Some...
Biological Effects of Radiation
Cancer Survival Analysis
Treatment Resistant Cancers
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...